Innovation Pharmaceuticals Inc (IPIX)

[tykundegex]

I agree, and think it's important (and often difficult) to judge whether it's simply the "market's perception" or an unfolding reality.

In the case of CTIX, I (personally) don't like the PRs which seem to be released from time to time in a effort to boost investor confidence (and PPS) at a time where there is no material news. This often leads to a reduced "trust" with some shareholders vis-à-vis the management. Of course, there is also the reality of sometimes needing a higher share price to fund (with less dilution) the business.

The question for CTIX is... is the market correct to have devalued the company ... has something changed? Did management make mistakes? Possibly IMO, but in the case of a biotech I'm far less worried about having CEO who knows how to run the company like a battleship, than I am having a CEO who knows how to advance the trials quickly and how to assess and unlock the potential value of the compounds they have. With CTIX, I'm pretty happy and find they're doing a great job.

A biotech investment is often binary... it either pays off big, or doesn't. No matter how much the company stumbles, if their science is sound, and their drugs get FDA approval, any investor lawsuits or lame PRs will be quickly forgotten.